You just read:

Phase 2b Study of Boehringer Ingelheim's Interferon-Free Hepatitis C Treatment Shows Undetectable Virus in HCV Genotype-1 Patients 12 Weeks After Treatment Ended (SVR12)

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Apr 19, 2012, 05:00 ET